New Delhi; 3rd Nov 2020: The Transforming India Diagnostics Event 2020 (TIDE) is scheduled for 1-3 Dec 2020. Organised by India’s leading in-vitro diagnostics organisation – J Mitra & Company, the theme of this 3-day virtual summit - is Covid, HIV and Celiac. The summit will drive participation of specialists of the industry, be it from IVD, POCT, Molecular Diagnostics, R&D and end-users. Key industry and segment thought leaders are ear-marked to speak and share their insights in a bid to look at ways and means of negating the effects of these extremely havoc-creating diseases. The broader aim of TIDE is to catalyse revolutionary changes in the Indian diagnostics space, by making diagnostics solutions more accessible and affordable for the masses, thereby playing a key role in the government’s mission of Swasth Bharat, Shreshth Bharat!
The timing of the Summit is extremely significant – 1st December is World AIDS Day and dedicated to raising awareness of the AIDS pandemic caused by the spread of HIV infection; The spread of corona is likely to increase due to the festive celebrity and hence the need to re-educate and re-affirm the actionable; and Celiac is emerging as a major epidemic for the world, especially the predominantly wheat-eating masses. Roughly, a third of the Indian population is genetically susceptible to develop Celiac disease. In case of all these three diseases – there is currently no known cure or treatment.
The global healthcare focus is shifting from treatment & cure to prevention & early detection.
The world has recognised the need for early warning systems in the healthcare segment – currently for Covid-19. This trend is going to continue for all forms of diagnostics and other diseases in times to come. As the first line of defence against the various diseases, the medical diagnostics industry is likely to herald a sea-change in the manner in which healthcare has been addressed throughout the world. It is going to focus more on proactive initiatives towards detection as opposed to the current practice of reactive-emergency procedures.
Diagnosis of patient has always remained a challenge for the medical fraternity and the quest to know more has benefitted with the development of novel ideas and technologies over the centuries.
The India Diagnostics Summit is a yeoman effort of J Mitra & Company to create awareness among all the stakeholders and understand the concerns and roadblocks in the diagnostics industry, and address the same with new opportunities, state-of-the-art technology and aggressive R&D, thereby empowering the country in its fight against the healthcare catastrophes.
Registration link: https://zoom.us/webinar/register/WN_BlhKAFjjT9eE44f6571iCA
TALKING DIAGNOSTICS, EMPOWERING DISRUPTION
Vertices Partners Announces Period Leave Each Month for team she vertices. Becom
India’s Pioneering, Trusted Online Mental Health Service, Healtheminds, Expand
Epillo launches connected virtual healthcare platform and digital therapeutics i
Unique for a Kerala hospital, KIMSHEALTH launches three comprehensive digital he
SCALING ANOTHER LEVEL
PHARMEASY TO ACQUIRE 66.1% STAKE IN THYROCARE FOR INR 4,546 CRS FROM DR A. VELUM
Elisa Antigen Test to Fast-pace India’s testing, monitoring, and Covid-19 mana
Connecting UP for a Better Future: Yogi Govt to enhance connectivity within the
MediBuddy launches Free Consultation Donation Campaign
StanPlus to expand its Red Ambulance network pan-India, collaborates with Grip I
UP Govt sets the target of vaccinating 10 crore people in the next three months.
Omar Sherief Mohammad appointed Head (IMEA region) for Roche Diabetes Care.
Trivitron Healthcare launches advanced diagnostic solutions for HbA1c based on H
J Mitra Launches India - First Covid-19 Neutralizing Antibody TestView All